BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 26217017)

  • 1. A Pro-Nerve Growth Factor (proNGF) and NGF Binding Protein, α2-Macroglobulin, Differentially Regulates p75 and TrkA Receptors and Is Relevant to Neurodegeneration Ex Vivo and In Vivo.
    Barcelona PF; Saragovi HU
    Mol Cell Biol; 2015 Oct; 35(19):3396-408. PubMed ID: 26217017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic and acute models of retinal neurodegeneration TrkA activity are neuroprotective whereas p75NTR activity is neurotoxic through a paracrine mechanism.
    Bai Y; Dergham P; Nedev H; Xu J; Galan A; Rivera JC; ZhiHua S; Mehta HM; Woo SB; Sarunic MV; Neet KE; Saragovi HU
    J Biol Chem; 2010 Dec; 285(50):39392-400. PubMed ID: 20943663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human ProNGF: biological effects and binding profiles at TrkA, P75NTR and sortilin.
    Clewes O; Fahey MS; Tyler SJ; Watson JJ; Seok H; Catania C; Cho K; Dawbarn D; Allen SJ
    J Neurochem; 2008 Nov; 107(4):1124-35. PubMed ID: 18808449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I interferons up-regulate the expression and signalling of p75 NTR/TrkA receptor complex in differentiated human SH-SY5Y neuroblastoma cells.
    Dedoni S; Olianas MC; Ingianni A; Onali P
    Neuropharmacology; 2014 Apr; 79():321-34. PubMed ID: 24333329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabry disease-associated globotriaosylceramide induces mechanical allodynia via activation of signaling through proNGF-p75
    Sugimoto J; Satoyoshi H; Takahata K; Muraoka S
    Eur J Pharmacol; 2021 Mar; 895():173882. PubMed ID: 33482180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NGF and ProNGF: Regulation of neuronal and neoplastic responses through receptor signaling.
    Bradshaw RA; Pundavela J; Biarc J; Chalkley RJ; Burlingame AL; Hondermarck H
    Adv Biol Regul; 2015 May; 58():16-27. PubMed ID: 25491371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different responses of PC12 cells to different pro-nerve growth factor protein variants.
    Soligo M; Albini M; Bertoli FL; Marzano V; Protto V; Bracci-Laudiero L; Minnone G; De Benedetti F; Chiaretti A; Mantuano E; Manni L
    Neurochem Int; 2019 Oct; 129():104498. PubMed ID: 31278975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Swedish Nerve Growth Factor Mutation (NGF
    Sung K; Ferrari LF; Yang W; Chung C; Zhao X; Gu Y; Lin S; Zhang K; Cui B; Pearn ML; Maloney MT; Mobley WC; Levine JD; Wu C
    J Neurosci; 2018 Apr; 38(14):3394-3413. PubMed ID: 29483280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential activity of the nerve growth factor (NGF) antagonist PD90780 [7-(benzolylamino)-4,9-dihydro-4-methyl-9-oxo-pyrazolo[5,1-b]quinazoline-2-carboxylic acid] suggests altered NGF-p75NTR interactions in the presence of TrkA.
    Colquhoun A; Lawrance GM; Shamovsky IL; Riopelle RJ; Ross GM
    J Pharmacol Exp Ther; 2004 Aug; 310(2):505-11. PubMed ID: 15051797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nerve growth factor-induced protein kinase C stimulation contributes to TrkA-dependent inhibition of p75 neurotrophin receptor sphingolipid signaling.
    Plo I; Bono F; Bezombes C; Alam A; Bruno A; Laurent G
    J Neurosci Res; 2004 Aug; 77(4):465-74. PubMed ID: 15264216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsic structural disorder of mouse proNGF.
    Paoletti F; Covaceuszach S; Konarev PV; Gonfloni S; Malerba F; Schwarz E; Svergun DI; Cattaneo A; Lamba D
    Proteins; 2009 Jun; 75(4):990-1009. PubMed ID: 19089979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ProNGF inhibits NGF-mediated TrkA activation in PC12 cells.
    Sobottka B; Reinhardt D; Brockhaus M; Jacobsen H; Metzger F
    J Neurochem; 2008 Dec; 107(5):1294-303. PubMed ID: 18796003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of transmembrane sequence and dimerization on cleavage of the p75 neurotrophin receptor by γ-secretase.
    Sykes AM; Palstra N; Abankwa D; Hill JM; Skeldal S; Matusica D; Venkatraman P; Hancock JF; Coulson EJ
    J Biol Chem; 2012 Dec; 287(52):43810-24. PubMed ID: 23105112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nerve growth factor beta/pro-nerve growth factor and their receptors in normal human oral mucosa.
    Hayashi K; Storesund T; Schreurs O; Khuu C; Husvik C; Karatsaidis A; Helgeland K; Martin-Zanca D; Schenck K
    Eur J Oral Sci; 2007 Oct; 115(5):344-54. PubMed ID: 17850422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p75 neurotrophin receptor enhances TrkA signalling by binding to Shc and augmenting its phosphorylation.
    Epa WR; Markovska K; Barrett GL
    J Neurochem; 2004 Apr; 89(2):344-53. PubMed ID: 15056278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of pro-nerve growth factor, neurotrophin receptor p75, and sortilin is associated with retrovirus-induced spongiform encephalomyelopathy.
    Stoica G; Lungu G; Kim HT; Wong PK
    Brain Res; 2008 May; 1208():204-16. PubMed ID: 18395188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of NGF/proNGF and Their Receptors TrkA, p75
    Marsland M; Dowdell A; Jiang CC; Wilmott JS; Scolyer RA; Zhang XD; Hondermarck H; Faulkner S
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nerve growth factor precursor proNGF exhibits neurotrophic activity but is less active than mature nerve growth factor.
    Fahnestock M; Yu G; Michalski B; Mathew S; Colquhoun A; Ross GM; Coughlin MD
    J Neurochem; 2004 May; 89(3):581-92. PubMed ID: 15086515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve growth factor (NGF)-mediated regulation of p75(NTR) expression contributes to chemotherapeutic resistance in triple negative breast cancer cells.
    Chakravarthy R; Mnich K; Gorman AM
    Biochem Biophys Res Commun; 2016 Sep; 478(4):1541-7. PubMed ID: 27577679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ProNGF and Neurodegeneration in Alzheimer's Disease.
    Fahnestock M; Shekari A
    Front Neurosci; 2019; 13():129. PubMed ID: 30853882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.